Altura Capital Makes Investment in Automation & Validation Solutions, Inc.
Summary
Ruben Taborda, former Chief Procurement Officer/Head of Supplier Diversity at Johnson & Johnson has been tapped as AVS new CEOMIAMI, Oct. 18, 2022 /PRNewswire/ -- Altura Capital, a lower and middle market credit enhanced impact investor, today announced it has successfully completed an investment in Automation & Validation Solutions, Inc., a leading diverse owned Pennsylvania-based consulting company specializing in Fortune-100 pharma, biotech, and med device companies. "AVS has a great reputation and plays a critical role in helping in the development and approval of new drugs, vaccines and medical devices," noted Jay Garcia, managing partner with Altura Capital. "We are very excited about this investment and Rubens leadership, as it opens new paths for diverse owners and talent to add value in high end solutions in the pharma and biomedical industries. "We remain steadfast in being a results-driven social impact investment firm, working in close collaboration with corporate america and their supplier diversity programs in the categories of consumer, business services, manufacturing and healthcare, to build strong and scalable firms in value-add verticals in which diverse suppliers have frequently never been," said Monika Mantilla, managing partner with Altura Capital. "AVS has built a unique business within the healthcare sector making them a perfect fit for our approach and our commitment to delivering returns and impact.